Drach J - Search Results

1

Antitumor activity of rituximab plus thalidomide in patients with relapsed/refractory mantle cell lymphoma.

Kaufmann H, Raderer M, Wöhrer S, Püspök A, Bankier A, Zielinski C, Chott A, Drach J. Kaufmann H, et al. Among authors: drach j. Blood. 2004 Oct 15;104(8):2269-71. doi: 10.1182/blood-2004-03-1091. Epub 2004 May 27. Blood. 2004. PMID: 15166030 Free article. Clinical Trial.

2

Thromboembolic events during treatment with thalidomide.

Urbauer E, Kaufmann H, Nösslinger T, Raderer M, Drach J. Urbauer E, et al. Among authors: drach j. Blood. 2002 Jun 1;99(11):4247-8. doi: 10.1182/blood-2001-12-0245. Blood. 2002. PMID: 12043695 Free article. Clinical Trial. No abstract available.

3

Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma.

Raderer M, Jäger G, Brugger S, Püspök A, Fiebiger W, Drach J, Wotherspoon A, Chott A. Raderer M, et al. Among authors: drach j. Oncology. 2003;65(4):306-10. doi: 10.1159/000074641. Oncology. 2003. PMID: 14707449

4

Effective treatment of primary plasma cell leukemia with thalidomide and dexamethasone - a case report.

Wöhrer S, Ackermann J, Baldia C, Seidl S, Raderer M, Simonitsch I, Drach J. Wöhrer S, et al. Among authors: drach j. Hematol J. 2004;5(4):361-3. doi: 10.1038/sj.thj.6200375. Hematol J. 2004. PMID: 15297854

5

Effective treatment of indolent non-hodgkin's lymphomas with mitoxantrone, chlorambucil and prednisone.

Wöhrer S, Raderer M, Kaufmann H, Hejna M, Chott A, Zielinski CC, Drach J. Wöhrer S, et al. Among authors: drach j. Onkologie. 2005 Feb;28(2):73-8. doi: 10.1159/000083223. Onkologie. 2005. PMID: 15662110

6

Treatment of mantle cell lymphoma: targeting the microenvironment.

Drach J, Seidl S, Kaufmann H. Drach J, et al. Expert Rev Anticancer Ther. 2005 Jun;5(3):477-85. doi: 10.1586/14737140.5.3.477. Expert Rev Anticancer Ther. 2005. PMID: 16001955 Review.

7

Routine application of the proton-pump inhibitor pantoprazole in patients with gastric lymphoma undergoing chemotherapy.

Wöhrer S, Bartsch R, Hejna M, Drach J, Raderer M. Wöhrer S, et al. Among authors: drach j. Scand J Gastroenterol. 2005 Oct;40(10):1222-5. doi: 10.1080/00365520510023440. Scand J Gastroenterol. 2005. PMID: 16265779

8

Rituximab, Ara-C, dexamethasone and oxaliplatin is safe and active in heavily pretreated patients with diffuse large B-cell lymphoma.

Woehrer S, Hejna M, Skrabs C, Drach J, Zielinski CC, Jaeger U, Raderer M. Woehrer S, et al. Among authors: drach j. Oncology. 2005;69(6):499-502. doi: 10.1159/000091031. Epub 2006 Jan 16. Oncology. 2005. PMID: 16424679

9

Activity of rituximab plus cyclophosphamide, doxorubicin/mitoxantrone, vincristine and prednisone in patients with relapsed MALT lymphoma.

Raderer M, Wohrer S, Streubel B, Drach J, Jager U, Turetschek K, Troch M, Puspok A, Zielinski CC, Chott A. Raderer M, et al. Among authors: drach j. Oncology. 2006;70(6):411-7. doi: 10.1159/000098555. Epub 2007 Jan 12. Oncology. 2006. PMID: 17220639

10

Bortezomib combined with rituximab and dexamethasone is an active regimen for patients with relapsed and chemotherapy-refractory mantle cell lymphoma.

Lamm W, Kaufmann H, Raderer M, Hoffmann M, Chott A, Zielinski C, Drach J. Lamm W, et al. Among authors: drach j. Haematologica. 2011 Jul;96(7):1008-14. doi: 10.3324/haematol.2011.041392. Epub 2011 Apr 12. Haematologica. 2011. PMID: 21486866 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

344 results

Search Page

Filters